Form 8-K - Current report:
SEC Accession No. 0001104659-22-096542
Filing Date
2022-08-31
Accepted
2022-08-31 16:13:24
Documents
98
Period of Report
2021-12-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K azyo-20211231x8k.htm   iXBRL 8-K 159927
2 EXHIBIT 23.1 azyo-20211231xex23d1.htm EX-23.1 3009
3 EXHIBIT 99.1 azyo-20211231xex99d1.htm   iXBRL EX-99.1 1177955
  Complete submission text file 0001104659-22-096542.txt   8134334

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA azyo-20211231.xsd EX-101.SCH 67995
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azyo-20211231_cal.xml EX-101.CAL 65290
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azyo-20211231_def.xml EX-101.DEF 325108
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE azyo-20211231_lab.xml EX-101.LAB 643960
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azyo-20211231_pre.xml EX-101.PRE 513874
92 EXTRACTED XBRL INSTANCE DOCUMENT azyo-20211231x8k_htm.xml XML 1358426
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

EIN.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39577 | Film No.: 221218099
SIC: 2836 Biological Products, (No Diagnostic Substances)